Publikationen von Masanori Nakayama

Takahashi, H.; Eguchi, J.; Watanabe, M.; Nakayama, M.; Wada, J.: Reduced Immunogenicity of COVID-19 Vaccine in Obese Patients with Type 2 Diabetes: A Cross-Sectional Study. ACTA MEDICA OKAYAMA 78 (2), S. 185 - 191 (2024)

Kawana, S.; Sugimoto, S.; Matsubara, K.; Choshi, H.; Tanaka, S.; Ishihara, M.; Habu, T.; Hashimoto, K.; Suzawa, K.; Shien, K. et al.; Miyoshi, K.; Okazaki, M.; Nakayama, M.; Toyooka, S.: Augmented humoral response to third and fourth dose of SARS-CoV-2 mRNA vaccines in lung transplant recipients. RESPIRATORY INVESTIGATION 62 (5), S. 804 - 810 (2024)

Matsumoto, N.; Hagiya, H.; Nakayama, M.; Furukawa, M.; Mitsuhashi, T.; Takao, S.; Otsuka, F.; Yorifuji, T.: Examining the association between vaccine reactogenicity and antibody titer dynamics after the third dose of BNT162b2 vaccine using a mixed-effects model. JOURNAL OF INFECTION AND CHEMOTHERAPY 29 (1), S. 39 - 42 (2023)

Mirzapour-Shafiyi, F.; Kametani, Y.; Hikita, T.; Hasegawa, Y.; Nakayama, M.: Numerical evaluation reveals the effect of branching morphology on vessel transport properties during angiogenesis. PLOS COMPUTATIONAL BIOLOGY 17 (6), e1008398 (2021)

Kobayashi, M.; Wakabayashi, I.; Suzuki, Y.; Fujiwara, K.; Nakayama, M.; Watabe, T.; Sato, Y.: Tubulin carboxypeptidase activity of vasohibin-1 inhibits angiogenesis by interfering with endocytosis and trafficking of pro-angiogenic factor receptors. ANGIOGENESIS (2020)

Li, M.; Nishio, S.-y.; Naruse, C.; Riddell, M.; Sapski, S.; Katsuno, T.; Hikita, T.; Mizapourshafiyi, F.; Smith, F. M.; Cooper, L. T. et al.; Lee, M. G.; Asano, M.; Boettger, T.; Krueger, M.; Wietelmann, A.; Graumann, J.; Day, B. W.; Boyd, A. W.; Offermanns, S.; Kitajiri, S.-i.; Usami, S.-i.; Nakayama, M.: Digenic inheritance of mutations in EPHA2 and SLC26A4 in Pendred syndrome. NATURE COMMUNICATIONS 11 (1), 1343 (2020)

Hartmann, C.; Schwietzer, Y. A.; Kummer, D.; Kirschnick, N.; Hoppe, E.; Thuering, E.-M.; Glaesner-Ebnet, M.; Brinkmann, F.; Gerke, V.; Reuter, S. et al.; Nakayama, M.; Ebnet, K.: The mitochondrial outer membrane protein SYNJ2BP interacts with the cell adhesion molecule TMIGD1 and can recruit it to mitochondria. BMC MOLECULAR AND CELL BIOLOGY 21 (1), 30 (2020)

Kawamura, A.; Kawamura, T.; Riddell, M.; Hikita, T.; Yanagi, T.; Umemura, H.; Nakayama, M.: Regulation of programmed cell death ligand 1 expression by atypical protein kinase C lambda/iota in cutaneous angiosarcoma. CANCER SCIENCE 110 (5), S. 1780 - 1789 (2019)

Ebnet, K.; Kummer, D.; Steinbacher, T.; Singh, A.; Nakayama, M.; Matis, M.: Regulation of cell polarity by cell adhesion receptors. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY 81, S. 2 - 12 (2018)

Hikita, T.; Mirzapourshafiyi, F.; Barbacena, P.; Riddell, M.; Pasha, A.; Li, M.; Kawamura, T.; Brandes, R. P.; Hirose, T.; Ohno, S. et al.; Gerhardt, H.; Matsuda, M.; Franco, C. A.; Nakayama, M.: PAR-3 controls endothelial planar polarity and vascular inflammation under laminar flow. EMBO REPORTS 19 (9), e45253 (2018)

Riddell, M.; Nakayama, A.; Hikita, T.; Mirzapourshafiyi, F.; Kawamura, T.; Pasha, A.; Li, M.; Masuzawa, M.; Looso, M.; Steinbacher, T. et al.; Ebnet, K.; Potente, M.; Hirose, T.; Ohno, S.; Fleming, I.; Gattenloehner, S.; Aung, P. P.; Thuy, P.; Yamasaki, O.; Yanagi, T.; Umemura, H.; Nakayama, M.: aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability. NATURE COMMUNICATIONS 9, 5357 (2018)

Eilken, H. M.; Dieguez-Hurtado, R.; Schmidt, I.; Nakayama, M.; Jeong, H.-W.; Arf, H.; Adams, S.; Ferrara, N.; Adams, R. H.: Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1. NATURE COMMUNICATIONS 8, 1574 (2017)

Brinkmann, B. F.; Steinbacher, T.; Hartmann, C.; Kummer, D.; Pajonczyk, D.; Mirzapourshafiyi, F.; Nakayama, M.; Weide, T.; Gerke, V.; Ebnet, K.: VE-cadherin interacts with cell polarity protein Pals1 to regulate vascular lumen formation. MOLECULAR BIOLOGY OF THE CELL 27 (18), S. 2811 - 2821 (2016)